Clinical Trials Directory

Trials / Completed

CompletedNCT00741559

Combined Role of Position Emission Tomography (PET) and Magnetoencephalography (MEG) in Nonlesional Epilepsy

Combined Role of PET and MEG in Nonlesional Epilepsy in Pediatric Population

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
59 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The first aim of this study are to evaluate the lobar concordance of FDG-PET and MEG with intracranial electrographic study in children with intractable partial epilepsy. The second aim is to determine if the combined role of FDG-PET and MEG improve detection of epileptogenic zone as defined by invasive intracranial recordings.

Detailed description

Children with poorly controlled epilepsy are extensively investigated with various tools including MR brain, electroencephalography (EEG), magnetoencephalography (MEG) or position emission tomography (PET) scans. When MR brain does not show an abnormality, the patient is said to have nonlesional epilepsy. In these cases, it is even more crucial to be able to identify the epileptogenic zone, depending on availability of investigative tool. Recognizing that individual modalities have limitations, the aim of this study is to determine if combining non-invasive investigations with MEG and PET, which respectively evaluate the electrical and metabolic activity of the brain, could improve the children with intractable nonlesional epilepsy with MEG and PET and compared this with invasive intracranial monitoring. The endpoint of the study being agreement on localizations of epileptogenic zone using PET and MEG individually and in combination and comparing this with invasive intracranial monitoring.

Conditions

Interventions

TypeNameDescription
DEVICEmagnetoencephalographyMEG studies are performed using a whole-head Omega 151-channel gradiometer system.
DEVICEPositron emission tomography (PET)An interictal FDG(fluoro-D-glucose)-PET will be obtained in a single 10 minute scanning session. PET scans will be obtained using a 3D acquisition technique, which will allow the use of a lower dose of radiotracer.
DEVICEMagnetic resonance imagingMR will be performed on a 1.5T or 3T system, using a combination of different sequences including sagittal T1, coronal and axial T2, FLAIR and proton density and axial 3D T1 weighted images.

Timeline

Start date
2008-03-01
Primary completion
2011-03-01
Completion
2011-06-01
First posted
2008-08-26
Last updated
2014-05-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00741559. Inclusion in this directory is not an endorsement.